Stewart Graham, PhD, received his graduate degree in 2009 from Queen's University Belfast studying the use of technology called high-resolution metabolomics to detect food fraud. Dr. Graham later applied this technology to the study of neurodegenerative diseases and subsequently became an Alzheimer's Research Trust fellow at Queen's University. In 2014, he was appointed as the director of metabolomics research at Beaumont Health and as an assistant professor at Oakland University William Beaumont School of Medicine in Michigan. To date, Dr. Graham has more than 10 years' experience using metabolomics to study neurodegenerative disease. He has recently started to integrate metabolomics with other technologies, such as epigenetics and proteomics, to garner a better understanding of neurodegenerative diseases. Using these combined technologies, Dr. Graham aims to identify the right drug at the right time for the right person with a neurodegenerative disease such as Parkinson's.